| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.22 | 5e-05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.83 | 0.0009 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.004 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.099 | 0.008 |